PT752246E - Kapa-opiatos para doencas inflamatorias dos intestinos - Google Patents
Kapa-opiatos para doencas inflamatorias dos intestinosInfo
- Publication number
- PT752246E PT752246E PT96109915T PT96109915T PT752246E PT 752246 E PT752246 E PT 752246E PT 96109915 T PT96109915 T PT 96109915T PT 96109915 T PT96109915 T PT 96109915T PT 752246 E PT752246 E PT 752246E
- Authority
- PT
- Portugal
- Prior art keywords
- kapa
- opiates
- intestines
- inflammatory diseases
- inflammatory
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 210000000936 intestine Anatomy 0.000 title 1
- 229940127240 opiate Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19523502A DE19523502A1 (de) | 1995-06-28 | 1995-06-28 | Kappa-Opiatagonisten für entzündliche Darmerkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT752246E true PT752246E (pt) | 2002-09-30 |
Family
ID=7765475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96109915T PT752246E (pt) | 1995-06-28 | 1996-06-20 | Kapa-opiatos para doencas inflamatorias dos intestinos |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US5776972A (enExample) |
| EP (1) | EP0752246B1 (enExample) |
| JP (2) | JP4415075B2 (enExample) |
| KR (1) | KR100501612B1 (enExample) |
| CN (1) | CN1119147C (enExample) |
| AR (1) | AR004671A1 (enExample) |
| AT (1) | ATE214275T1 (enExample) |
| AU (1) | AU708699B2 (enExample) |
| BR (1) | BR9602915A (enExample) |
| CA (1) | CA2179955C (enExample) |
| CO (1) | CO4700454A1 (enExample) |
| CZ (1) | CZ289805B6 (enExample) |
| DE (2) | DE19523502A1 (enExample) |
| DK (1) | DK0752246T3 (enExample) |
| ES (1) | ES2171577T3 (enExample) |
| HU (1) | HU226976B1 (enExample) |
| NO (1) | NO309674B1 (enExample) |
| PL (1) | PL185537B1 (enExample) |
| PT (1) | PT752246E (enExample) |
| RU (1) | RU2190401C2 (enExample) |
| SI (1) | SI0752246T1 (enExample) |
| SK (1) | SK283497B6 (enExample) |
| TR (1) | TR199600497A2 (enExample) |
| TW (1) | TW430557B (enExample) |
| UA (1) | UA51615C2 (enExample) |
| ZA (1) | ZA965480B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6303611B1 (en) * | 1996-03-08 | 2001-10-16 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
| US5763445A (en) | 1996-03-08 | 1998-06-09 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| US6239154B1 (en) | 1996-03-08 | 2001-05-29 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| EP0948964B1 (en) * | 1996-12-02 | 2003-04-02 | Kyorin Pharmaceutical Co., Ltd. | Novel n-substituted pyrrolidine derivatives and process for preparing the same |
| US6133307A (en) * | 1997-04-30 | 2000-10-17 | Warner-Lambert Company | Certain benzofuranyl-N-[pyrrolidin-1-YL]-N-methyl-acetamide derivatives useful as opioid agonists |
| US5760023A (en) * | 1997-07-14 | 1998-06-02 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| JP2003526594A (ja) * | 1997-07-14 | 2003-09-09 | アドラー コーポレーション | カッパ・アゴニスト抗掻痒薬学的製剤およびそれにより掻痒を治療する方法 |
| DE19827633A1 (de) * | 1998-04-20 | 1999-10-21 | Merck Patent Gmbh | Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid |
| DE10116978A1 (de) * | 2001-04-05 | 2002-10-10 | Merck Patent Gmbh | Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase |
| US20050176746A1 (en) * | 2002-05-17 | 2005-08-11 | Frank Weber | Use of compounds that are effective as selective opiate receptor modulators |
| AU2003269399A1 (en) * | 2002-11-01 | 2004-05-25 | Pfizer Products Inc. | Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination |
| DE10259245A1 (de) * | 2002-12-17 | 2004-07-01 | Merck Patent Gmbh | Derivate des Asimadolins mit kovalent gebundenen Säuren |
| TWI334349B (en) * | 2003-07-04 | 2010-12-11 | Santen Pharmaceutical Co Ltd | Pain threshold reduction depressant |
| US7642274B2 (en) | 2003-07-04 | 2010-01-05 | Santen Pharmaceutical Co., Ltd. | Inhibitor of pain threshold decrease |
| US20080090859A1 (en) * | 2003-10-30 | 2008-04-17 | Tioga Pharmaceuticals, Inc. | Use of Selective Opiate Receptor Modulators In the Treatment Of Neuropathy |
| US7160902B2 (en) * | 2003-11-14 | 2007-01-09 | Adolor Corporation | Amide derivatives and methods of their use |
| PL2136801T3 (pl) * | 2007-03-30 | 2013-01-31 | Tioga Pharmaceuticals Inc | Agoniści kappa-opioidów do leczenia zespołu jelita drażliwego w postaci zmiennej i z dominującą biegunką |
| CN104271552B (zh) * | 2012-03-05 | 2017-08-08 | 雷迪博士实验室有限公司 | 作为kappa阿片样物质受体(kor)激动剂的取代的杂环乙酰胺 |
| WO2015114660A1 (en) * | 2014-01-24 | 2015-08-06 | Cadila Healtchare Limited | Novel heterobicyclic compounds as kappa opioid agonists |
| WO2018119108A1 (en) | 2016-12-21 | 2018-06-28 | Tioga Pharmaceuticals Inc. | Splid pharmaceutical formulations of asimadoline |
| WO2019122361A1 (en) | 2017-12-22 | 2019-06-27 | Dr. August Wolff Gmbh & Co. Kg Arzneimittel | Asimadoline for use in treating pulmonary diseases, vascular diseases, and sepsis |
| EP3932390A1 (en) | 2020-07-02 | 2022-01-05 | Dr. August Wolff GmbH & Co. KG Arzneimittel | Topical gel formulation containing asimadoline |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663343A (en) * | 1985-07-19 | 1987-05-05 | Warner-Lambert Company | Substituted naphthalenyloxy-1,2-diaminocyclohexyl amide compounds |
| DE4034785A1 (de) * | 1990-11-02 | 1992-05-07 | Merck Patent Gmbh | 1-(2-arylethyl)-pyrrolidine |
| US5232978A (en) * | 1988-12-23 | 1993-08-03 | Merck Patent Gesellschaft Mit Beschrankter Haftung | 1-(2-arylethyl)-pyrrolidines |
| US5232266A (en) * | 1989-07-24 | 1993-08-03 | Mork William J | Upholstered article of furniture with interchangeable seating module |
| DE4215213A1 (de) * | 1992-05-09 | 1993-11-11 | Merck Patent Gmbh | Arylacetamide |
-
1995
- 1995-06-28 DE DE19523502A patent/DE19523502A1/de not_active Withdrawn
-
1996
- 1996-06-12 TR TR96/00497A patent/TR199600497A2/xx unknown
- 1996-06-20 SI SI9630475T patent/SI0752246T1/xx unknown
- 1996-06-20 DE DE59608861T patent/DE59608861D1/de not_active Expired - Lifetime
- 1996-06-20 ES ES96109915T patent/ES2171577T3/es not_active Expired - Lifetime
- 1996-06-20 EP EP96109915A patent/EP0752246B1/de not_active Expired - Lifetime
- 1996-06-20 PT PT96109915T patent/PT752246E/pt unknown
- 1996-06-20 DK DK96109915T patent/DK0752246T3/da active
- 1996-06-20 AT AT96109915T patent/ATE214275T1/de active
- 1996-06-24 AU AU56162/96A patent/AU708699B2/en not_active Ceased
- 1996-06-25 CZ CZ19961866A patent/CZ289805B6/cs not_active IP Right Cessation
- 1996-06-26 CA CA002179955A patent/CA2179955C/en not_active Expired - Fee Related
- 1996-06-26 JP JP16598896A patent/JP4415075B2/ja not_active Expired - Fee Related
- 1996-06-26 RU RU96112771/14A patent/RU2190401C2/ru not_active IP Right Cessation
- 1996-06-27 TW TW085107762A patent/TW430557B/zh not_active IP Right Cessation
- 1996-06-27 SK SK843-96A patent/SK283497B6/sk not_active IP Right Cessation
- 1996-06-27 ZA ZA965480A patent/ZA965480B/xx unknown
- 1996-06-27 CN CN96110142A patent/CN1119147C/zh not_active Expired - Fee Related
- 1996-06-27 UA UA96062557A patent/UA51615C2/uk unknown
- 1996-06-27 KR KR1019960024568A patent/KR100501612B1/ko not_active Expired - Fee Related
- 1996-06-27 BR BR9602915A patent/BR9602915A/pt not_active Application Discontinuation
- 1996-06-27 PL PL96314996A patent/PL185537B1/pl not_active IP Right Cessation
- 1996-06-27 US US08/671,502 patent/US5776972A/en not_active Expired - Lifetime
- 1996-06-27 NO NO962720A patent/NO309674B1/no unknown
- 1996-06-28 AR ARP960103374A patent/AR004671A1/es not_active Application Discontinuation
- 1996-06-28 HU HU9601798A patent/HU226976B1/hu not_active IP Right Cessation
- 1996-06-28 CO CO96034158A patent/CO4700454A1/es unknown
-
1998
- 1998-02-20 US US09/027,228 patent/US5977161A/en not_active Expired - Lifetime
-
2008
- 2008-04-23 JP JP2008112917A patent/JP5308056B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT752246E (pt) | Kapa-opiatos para doencas inflamatorias dos intestinos | |
| PT977748E (pt) | Derivados benzopirano substituidos para o tratamento de inflamacao | |
| PT944631E (pt) | Novos derivados substituidos de pirazole para tratamento de doencas cardiovasculares | |
| BR9510256A (pt) | Derivados de ácido 3-aril-tetrônico | |
| BR9600453A (pt) | Suporte para monitor | |
| FI950910A0 (fi) | Rasvahappojohdannaiset | |
| FI973292A7 (fi) | Substituoituja isoksatsoleja tulehduksen hoitamiseksi | |
| NO965343D0 (no) | Rålegemiddelholdig for | |
| BR9507179A (pt) | Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena | |
| FI950909A7 (fi) | Rasvahappojohdannaisia | |
| KR970000222A (ko) | 팩리택셀 유도체의 전구약물 | |
| PT983275E (pt) | Novos derivados do triptolido vantajosos para o tratamento de doencas autoimunes | |
| KR970707125A (ko) | 염증성 장 질환 치료용의 5-아미노살리실산의아조 유도체(azo derivatives of 5-aminosalicylic acid for treatment of inflammatory bowel-disease) | |
| FI971527A7 (fi) | Indolijohdannaisten käyttö erilaisten sairauksien hoitoon | |
| NO965233D0 (no) | Deacetoksytaksol-derivat | |
| ITMI950532A0 (it) | Derivato di aminotetralina per la terapia di malattie cardiovascolari | |
| EE03437B1 (et) | Benseenamiidid neurodegeneratiivsete haiguste ravimiseks | |
| FI970195A7 (fi) | Trifluormetyylikinoliinikarboksyylihappojohdannainen | |
| BR1100473A (pt) | Compostos úteis para tratamento de doenças alérgicas e inflamatórias | |
| DE69427775D1 (de) | Dimethylfurancarboxamilid-derivat | |
| KR960004255U (ko) | 에어택커의 슛팅부 구조 | |
| KR960010231U (ko) | 에어택커의 슛팅부 구조 | |
| KR970009735U (ko) | 연사 정경용 크릴 구조 | |
| KR980003762U (ko) | 제품 브랜드의 고정 장치 | |
| IT1293464B1 (it) | Apparecchio elettromedicale per la cura di patologie infiammatorie acute |